Series B

Nord Anglia Education empowers students to solve real-world problems, from building prosthetics to restoring coral reefs, through a unique metacognitive approach.

Scrum Alliance's new course helps agile teams move beyond activity tracking to prove their real business value with data-driven, outcome-focused metrics.

A new global consortium aims to break the antibiotic R&D logjam, using open science and AI to combat the growing superbug crisis threatening millions.

LiveWorld unveils a new AI roadmap for pharma, promising a safer, human-guided approach to tackle compliance and build trust in a high-risk industry.

An Israeli startup's laser-based processor is making waves in high-performance computing, offering a practical, room-temperature alternative to quantum.

GSK's subsidiary Tesaro inks a deal worth up to $285M with Alteogen to create an under-the-skin version of its cancer drug Jemperli.

Deeplumen's new tool for Google's UCP signals a massive shift to 'agentic commerce,' where AIs shop for you. But are brands ready for this new world?

Following a spin-out and $5M financing, new explorer Blue Jay Gold aims to unlock value at its Steller Project and list on the TSX Venture Exchange.

American Lithium Minerals acquires a high-grade gold claim in BC's Golden Triangle while pivoting to a revolutionary but risky blockchain financing model.

Slingshot Aerospace's TALOS AI will create unpredictable, machine-speed adversaries, revolutionizing how Guardians prepare for orbital conflict.

Four startups won the UAE FoodTech Challenge, sharing $2M to scale their solutions for food production and waste reduction from the UAE to the Global South.

As Moelis & Co. prepares to report its 2025 results, investors are watching to see if the firm capitalized on a record year for dealmaking.

With a new CRO known for driving acquisitions and IPOs, RunSafe Security aims to dominate the critical infrastructure protection market amid rising threats.

Amid rapid industry consolidation, doctor-owned DSO PepperPointe Partnerships adds three VPs to scale its unique model and support continued expansion.

Biotech veteran Kamran Tavangar, who built a multi-billion dollar company at LabCentral, returns to lead its science strategy and shape the future of innovation.

A new partnership aims to move AI from costly experiments to real-world value in biopharma, combining specialized agents with strategic implementation.

With a key FDA decision looming, Orca Bio's massive new funding aims to commercialize a therapy that could make curative transplants safer for more patients.

Pharma giant Lilly and AI biotech BigHat are teaming up to solve a critical flaw in AI drug discovery, aiming to unlock a new generation of therapies.

TwelveStone Health Partners and AI firm Tennr are teaming up to automate patient referrals, aiming to slash wait times and improve access to vital care.

A landmark $1.2M order for its advanced LineaDNA validates the firm's biotech arm, but can scientific success balance its new, volatile crypto strategy?